BACKGROUND: Coxiella burnetii, an obligate intracellular organism, is the causative agent of the zoonotic disease Q fever. The seroprevalence rate for Q fever in the United States is 3.1%, suggesting a high number of infections each year. However, fewer than 200 cases of Q fever are reported to the CDC annually. This discrepancy is likely the result of underutilized diagnostics and a high percentage (>50%) of asymptomatic infections. The detection of C. burnetii in patient blood during the first 2 to 3 weeks of infection raises the possibility that the organism could be present in donated human blood. The purpose of this study was to determine if extracellular C. burnetii would be stable in blood under normal storage conditions. STUDY DESIGN AND METHODS: Donated human blood was separated into whole blood, leukoreduced whole blood, red blood cells, and plasma. Each component was spiked with purified, extracellular C. burnetii strain Nine Mile Phase 1, and the viability and infectivity of the organisms were tested weekly. RESULTS: C. burnetii did not decrease in viability or the ability to infect cells after storage in any of the blood products, even after 6 weeks of storage at 1 to 6 °C. CONCLUSIONS: Extracellular C. burnetii can survive and remain infectious in donated blood products.
BACKGROUND: Coxiella burnetii, an obligate intracellular organism, is the causative agent of the zoonotic disease Q fever. The seroprevalence rate for Q fever in the United States is 3.1%, suggesting a high number of infections each year. However, fewer than 200 cases of Q fever are reported to the CDC annually. This discrepancy is likely the result of underutilized diagnostics and a high percentage (>50%) of asymptomatic infections. The detection of C. burnetii in patient blood during the first 2 to 3 weeks of infection raises the possibility that the organism could be present in donated human blood. The purpose of this study was to determine if extracellular C. burnetii would be stable in blood under normal storage conditions. STUDY DESIGN AND METHODS: Donated human blood was separated into whole blood, leukoreduced whole blood, red blood cells, and plasma. Each component was spiked with purified, extracellular C. burnetii strain Nine Mile Phase 1, and the viability and infectivity of the organisms were tested weekly. RESULTS:C. burnetii did not decrease in viability or the ability to infect cells after storage in any of the blood products, even after 6 weeks of storage at 1 to 6 °C. CONCLUSIONS: Extracellular C. burnetii can survive and remain infectious in donated blood products.
Authors: Boris M Hogema; Ed Slot; Michel Molier; Peter M Schneeberger; Mirjam H Hermans; Erik J van Hannen; Wim van der Hoek; H Theo Cuijpers; Hans L Zaaijer Journal: Transfusion Date: 2011-07-14 Impact factor: 3.157
Authors: Peter M Schneeberger; Mirjam H A Hermans; Erik J van Hannen; Jeroen J A Schellekens; Alexander C A P Leenders; Peter C Wever Journal: Clin Vaccine Immunol Date: 2009-12-23
Authors: Anders Omsland; Paul A Beare; Joshua Hill; Diane C Cockrell; Dale Howe; Bryan Hansen; James E Samuel; Robert A Heinzen Journal: Appl Environ Microbiol Date: 2011-04-08 Impact factor: 4.792
Authors: Wim van der Hoek; Bart Versteeg; Jamie C E Meekelenkamp; Nicole H M Renders; Alexander C A P Leenders; Ineke Weers-Pothoff; Mirjam H A Hermans; Hans L Zaaijer; Peter C Wever; Peter M Schneeberger Journal: Clin Infect Dis Date: 2011-06-15 Impact factor: 9.079
Authors: Amanda D Loftis; Will K Reeves; Daniel E Szumlas; Magda M Abbassy; Ibrahim M Helmy; John R Moriarity; Gregory A Dasch Journal: Exp Appl Acarol Date: 2006-09-27 Impact factor: 2.132
Authors: Alicia D Anderson; Deanna Kruszon-Moran; Amanda D Loftis; Geraldine McQuillan; William L Nicholson; Rachel A Priestley; Amanda J Candee; Nicole E Patterson; Robert F Massung Journal: Am J Trop Med Hyg Date: 2009-10 Impact factor: 2.345
Authors: Bruce H Noden; Filippus I Tshavuka; Berta E van der Colf; Israel Chipare; Rob Wilkinson Journal: PLoS One Date: 2014-09-26 Impact factor: 3.240